{"abstract":"This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the following U.S. Patents and Patent Applications to Bavarian Nordic Immunotherapeutics (\"BNIT\") located in Mountain View, CA, USA:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2013/02/20/2013-03799.html","cfr_references":[],"citation":"78 FR 11895","comment_url":null,"comments_close_on":"2013-03-22","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before March 22, 2013 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2013-03799","effective_on":null,"end_page":11896,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2013/02/20/2013-03799.xml","html_url":"https://www.federalregister.gov/documents/2013/02/20/2013-03799/prospective-grant-of-exclusive-license-development-of-muc-1-tumor-associated-antigens-as-cancer","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2013-03799?publication_date=2013-02-20","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2013-02-20/2013-03799/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":94,"last_updated":"2026-09-22 20:15:08 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2013-02-20/pdf/2013-03799.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2013-03799.pdf?1361281764","publication_date":"2013-02-20","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2013/02/20/2013-03799.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2013-03-24T05:00:45Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":11895,"subtype":null,"title":"Prospective Grant of Exclusive License: Development of MUC-1 Tumor Associated Antigens as Cancer Vaccines for Bladder Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer and Pancreatic Cancer","toc_doc":"Development of MUC1 Tumor Associated Antigens as Cancer Vaccines, etc.","toc_subject":"Exclusive Licenses:","topics":[],"type":"Notice","volume":78}